Vicia ervilia (Bitter Vetch)

Bitter vetch (Vicia ervilia) is a legume rich in protein (24–26%) and bioactive polyphenols, including tannins and flavonoids, that contribute to its antioxidant and antiproliferative properties. Its antiproliferative activity against colon tumor cells in vitro is attributed partly to lectins and condensed tannins that disrupt cell proliferation signaling.

Origin & History

Vicia ervilia (bitter vetch) is an ancient leguminous crop from the Mediterranean region, historically cultivated for food and animal feed. The seeds are processed through soaking, grinding, autoclaving, or cooking to reduce anti-nutritional compounds like canavanine and tannins before dietary use.

Historical & Cultural Context

Vicia ervilia has been cultivated since ancient times in Mediterranean countries as both a food crop and animal feed. By the early 20th century, it was largely replaced by higher-yield crop options, with no specific traditional medicine uses documented.

Health Benefits

• Contains high protein content (24-26%) and minerals including iron (340 ppm) and copper (46.7 ppm) - based on compositional analysis only
• Shows in vitro antiproliferative effects against Caco-2 colon tumor cells - preliminary laboratory evidence only
• Provides antioxidant activity attributed to polyphenols (0.09-0.19%) including luteolin, kaempferol, and quercetin - in vitro studies only
• Contains canavanine which demonstrates antitumor activity through aberrant protein formation - general mechanism, not specific to bitter vetch clinical use
• Serves as a nutrient-dense food source when properly processed - traditional use, no clinical evidence

How It Works

Condensed tannins and flavonoids in Vicia ervilia scavenge reactive oxygen species by donating hydrogen atoms to free radicals, inhibiting lipid peroxidation chain reactions. Vetch lectins may bind specific glycoprotein receptors on tumor cell surfaces, interfering with mitogenic signaling and inducing apoptosis in Caco-2 colon cancer cells in vitro. Additionally, its iron and copper content supports metalloenzyme activity, including superoxide dismutase (SOD), contributing to endogenous antioxidant defense.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Vicia ervilia in biomedical contexts. Available research consists only of in vitro studies showing seed extract inhibition of Caco-2 colon tumor cell proliferation and compositional analyses focused on nutritional content for animal feed applications.

Clinical Summary

Evidence for Vicia ervilia's health effects is largely limited to in vitro and compositional studies; no robust randomized controlled trials in humans have been published to date. Laboratory studies demonstrate antiproliferative effects against Caco-2 colon tumor cells, though these are preliminary findings that cannot be extrapolated to human cancer prevention or treatment. Nutritional analyses confirm meaningful protein density (24–26%), iron (~340 ppm), and copper (~46.7 ppm), suggesting potential utility as a dietary protein and mineral source. The overall evidence base is preclinical, and human efficacy, optimal dosage, and bioavailability remain unestablished.

Nutritional Profile

Protein: 24–26% of dry weight, rich in globulins and albumins with notable levels of lysine but limited in sulfur-containing amino acids (methionine, cysteine), reducing overall biological value unless complemented with cereals. Carbohydrates: ~55–60% of dry weight, predominantly starch (~45–50%) with moderate dietary fiber (~8–12%). Fat: low at ~1.5–2.5%, with a favorable unsaturated fatty acid profile including linoleic acid (C18:2, ~45–55% of total fatty acids) and oleic acid (C18:1, ~25–30%). Minerals: iron ~340 ppm (3.4 mg/100g), copper ~46.7 ppm (4.67 mg/100g), phosphorus ~350–450 mg/100g, potassium ~800–1000 mg/100g, calcium ~80–120 mg/100g, magnesium ~120–150 mg/100g, zinc ~3–5 mg/100g; mineral bioavailability is significantly reduced by high phytic acid content (~0.5–1.2%), which chelates divalent cations—soaking, germination, and cooking partially mitigate this effect. Polyphenols: total phenolics ~0.09–0.19% of dry weight, with identified flavonoids including luteolin, kaempferol, quercetin, and their glycosides, which contribute to measured in vitro antioxidant capacity (DPPH and ABTS assays). Anti-nutritional factors: contains canavanine (a non-protein amino acid and arginine analog, potentially toxic at high intakes), trypsin inhibitors, lectins, tannins (~0.3–0.8% as catechin equivalents), and saponins; these are substantially reduced (50–80%) by traditional processing methods such as prolonged soaking, boiling, and fermentation. B-vitamins present include thiamine (B1, ~0.4–0.6 mg/100g), riboflavin (B2, ~0.2–0.3 mg/100g), and niacin (B3, ~2–3 mg/100g). Amino acid profile includes relatively high glutamic acid (~15–18% of total amino acids) and aspartic acid (~10–12%). Resistant starch fraction may contribute to prebiotic effects, though this has not been clinically validated. Overall, bioavailability of nutrients is moderate and highly dependent on processing; raw or minimally processed seeds are not recommended for consumption due to anti-nutritional and potentially toxic compounds.

Preparation & Dosage

No clinically studied dosage ranges exist for human consumption. Processing methods studied in animal feed include soaking for 12-47 hours or autoclaving to reduce anti-nutrients. Bitter vetch flour has been incorporated into bread for mineral enrichment, but no standardized human dosages are established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other legumes, digestive enzymes, vitamin C (for iron absorption), probiotics, fiber supplements

Safety & Interactions

Raw Vicia ervilia contains neurotoxic beta-cyanoalanine and the antinutritional factors vicine and convicine, which can trigger hemolytic episodes in individuals with G6PD deficiency (favism), similar to fava beans. Proper soaking, boiling, and dehulling significantly reduces these compounds but may not eliminate risk entirely for sensitive populations. No clinically documented drug interactions have been established, though high tannin content may theoretically reduce iron and mineral absorption from co-ingested foods or supplements. Pregnant or breastfeeding women and individuals with G6PD deficiency should avoid bitter vetch consumption until safety data are available.